RxDoctor Payments Data

Melanie Webb, NP

Nurse Practitioner · Salisbury, NCNPI 1659795029

Payments from drug & device makers

$1,443in general payments, 2019–2025

Across 46 payments — averaging $31.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$379
  • AstraZeneca$190
  • Incyte Corporation$135
  • E.r. Squibb & Sons, L.L.C.$127
  • Tempus AI, Inc$123
  • Johnson & Johnson$70
  • plus $418 from 14 others

What the payments were for

  • Food & beverage$1,13679%
  • Education$30721%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,443 in reported general payments places this provider in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$27,441
Medicare patients
92
Services billed
351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide29$408,878
XalkoriCrizotinib12$257,557
RevlimidLenalidomide13$210,586
CalquenceAcalabrutinib Maleate13$199,780
ImbruvicaIbrutinib13$198,833
Abiraterone Acetate50$53,240
Oxycodone Hcl36$1,054
Ondansetron Hcl53$593
Dexamethasone16$583
ValacyclovirValacyclovir Hcl18$486
Letrozole21$467
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$380
Prochlorperazine Maleate22$359
Potassium Chloride37$268
Gabapentin23$245

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerXalkori$18$257,55712 claims
Bristol Myers SquibbRevlimid$55$210,58613 claims
AstraZenecaCalquence$190$199,78013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Salisbury

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →